Human ZBP1 is a potent inducer of cell death through mechanisms divergent from mouse ZBP1.

Human ZBP1 induces cell death more potently than mouse ZBP1, relying on RIPK1 and all three RHIM domains, with distinct signaling mechanisms.

• Why it matters: Understanding the differences between human and mouse ZBP1 is crucial for translating preclinical findings into effective human therapies, especially for cancer and inflammatory diseases.
• What they did: The study compared human and mouse ZBP1, demonstrating that human ZBP1 triggers cell death via RIPK1-dependent, RIPK3-independent pathways, requiring all three RHIM domains and specific C-terminal regions.
• The result: Findings reveal fundamental mechanistic differences in ZBP1 signaling between species, emphasizing the need to consider these divergences in developing targeted treatments and improving translational research.